Found 0 matching trials
Evaluation of GI001 for Relapsed or Refractory B-cell Non-Hodgkin Lymphoma EARLY_PHASE1 The goal of this clinical trial is to evaluate the safety, tolerability, an...
Show More Location
Multiple Locations
Learn More & Join Trial
CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris NA This is an investigator-initiated, single-center, single-arm, open-label ex...
Show More Location
Traditional Chinese and Western Medicine Hospital of Wuhan, Wuhan, Hubei
Learn More & Join Trial
CD19 CAR-T Consolidation Therapy for Acute Lymphoblastic Leukemia PHASE1 This is a single-arm, open-label, single-center, phase I/II study to determ...
Show More Status
Active Not Recruiting
Location
The First Affliated Hospital of Soochow University
Learn More & Join Trial
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis PHASE1 RESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Show More Location
Multiple Locations
Learn More & Join Trial
CD19-CAR Immunotherapy for Childhood Acute Lymphoblastic Leukemia (ALL) PHASE1 The aim of this clinical trial is to evaluate the feasibility, safety and b...
Show More Location
Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum
Learn More & Join Trial
Study Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and Lymphoma PHASE1 The purpose of this study is to evaluate the safety and effectiveness of CA...
Show More Location
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Learn More & Join Trial
Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCL PHASE2 This study is designed to evaluate the efficacy and safety of rimegepant in...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) PHASE1 This study is a preliminary investigation, with a single-group design, not ...
Show More Location
District One Hospital
Learn More & Join Trial
CAR-T for Children With Relapsed and Refractory Acute Lymphoblastic Leukemia EARLY_PHASE1 In this study, CAR-T will be administered to children with acute lymphoblas...
Show More Location
No.2 Hospital of Hebei Medical University
Learn More & Join Trial
Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure PHASE2 The goal of this clinical trial is to evaluate whether the drug Loncastuxim...
Show More Location
Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo
Learn More & Join Trial